The Centers for Medicare & Medicaid Services today announced new opportunities for states to design innovative service delivery systems for adults with serious mental illness and children with serious emotional disturbance, including Section 1115 waivers for short-term residential treatment services in an Institution for Mental Disease. While CMS has approved 17 state waivers to pay for IMD treatment for substance use disorders, including opioid use disorders, the new guidance will allow states to pursue waivers to pay for community and residential treatment services for the full continuum of mental health and SUDs.

 

“More treatment options for serious mental illness are needed, and that includes more inpatient and residential options,” said Health and Human Services Secretary Alex Azar. “As with the SUD waivers, we will strongly emphasize that inpatient treatment is just one part of what needs to be a complete continuum of care, and participating states will be expected to take action to improve community-based mental health care.”

 

CMS outlined the new waiver opportunities in a letter to state Medicaid directors, which also describes existing opportunities to support innovative service delivery systems for adults with serious mental illness and children with serious emotional disturbance.

 

“America’s hospitals and health systems commend Secretary Azar’s announcement regarding CMS guidance that will offer additional flexibility for state Medicaid agencies and providers to work together to better care for people with serious mental health conditions,” said AHA Executive Vice President Tom Nickels. “In 2016, approximately 10 million adults in the United States had a serious mental illness, but only 65 percent received mental health services in that year. … This guidance will lessen barriers to care for those in need of these services and increase access to quality behavioral health care.”      

Related News Articles

Headline
The National Academies of Sciences, Engineering, and Medicine Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain…
Headline
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…
Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
The New Hampshire Hospital Association, along with hospitals across the state, recently filed a motion to intervene in a federal lawsuit filed against the…
Headline
U.S. overdose death rates linked to synthetic opioids increased more than 45 percent in 2017, likely driven by illicitly manufactured fentanyl, according to a…